Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 6Obesity 5Sexual Infantilism 4Craniopharyngioma 3Overweight 2Weight Loss 1Insulin Resistance 1Fatty Liver 1Diabetes Mellitus, Type 1 1

Interventions

Metformin 30Exercise 8Pioglitazone 7Inositol 6Insulin 4Acupuncture Therapy 4High-Intensity Interval Training 3Ethinyl Estradiol 3salicylsalicylic acid 2drospirenone and ethinyl estradiol combination 2Water 2Tablets 2Sugars 2Resistance Training 2Preoperative Exercise 2Folic Acid 2Diet Therapy 2Cyproterone Acetate 2Caloric Restriction 2Biguanides 2ziprasidone 1maltodextrin 1lime 1licogliflozin 1exendin (9-39) 1drospirenone 1cinnulin PF 1adrenosterone 1Zoledronic Acid 1World Health Organization oral rehydration solution 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Insulin Resistance × Exenatide × Clear all
NCT00344851 2007-07-11

Exenatide and Metformin Therapy in Overweight Women With PCOS

Metabolic Center of Louisiana Research Foundation

Phase 2 Completed
60 enrolled

Insulin Resistance, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡